Nexium (Esomeprazole Magnesium Trihydrate)

Esomeprazole selectively and irreversibly blocks the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the secretory surface of parietal cells. This inhibition stops the final step of gastric acid secretion, leading to a sustained decrease in both basal and stimulated acid output.

The appropriate dose of Nexium is determined by the prescribing healthcare professional based on the specific indication, patient age, renal function, and treatment duration. Dosage regimens may vary, and patients should follow the prescriber’s instructions without self‑adjusting the dose.

Safety data for esomeprazole during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus. Breastfeeding mothers should consult their physician, as the drug is excreted in small amounts in breast milk.

To place an order, submit an enquiry on the Nexium product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nexium (esomeprazole) is the S‑enantiomer of omeprazole and generally provides more consistent acid suppression with a slightly longer half‑life. Compared with other PPIs such as lansoprazole or pantoprazole, it may achieve faster symptom relief in some patients, though clinical outcomes are broadly similar across the class.

Store Nexium at room temperature, below 25 °C, in its original packaging to protect it from moisture and excessive heat. Keep the product out of reach of children and avoid exposure to direct sunlight or humidity that could compromise tablet integrity.

Nexium is taken orally, usually as a whole tablet swallowed with water. It is commonly recommended to take the dose before a meal, often in the morning, but patients should follow the specific timing advised by their prescriber.

Serious risks include Clostridioides difficile‑associated diarrhea, severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, liver enzyme elevations, low magnesium levels with prolonged use, and an increased risk of bone fractures when therapy extends beyond one year.

Nexium should be avoided in patients with known hypersensitivity to esomeprazole or any component of the formulation. Caution is advised for individuals with severe liver disease, those taking medications that require an acidic environment for absorption, and patients with a history of osteoporosis when long‑term therapy is considered.